Coming-out in Body Integrity Dysphoria

Maya Berger,

Aglaja Stirn,

Erich Kasten

Создана Авг. 19, 2022

The term body integrity dysphoria (BID) describes a discrepancy between the actual anatomical body constitution and the mentally represented body of a physically impaired person, which is often experienced as chronically dysphoric as well as the resulting desire of the affected person to have a (permanent) physical impairment (amputation, paralysis, etc.) in order to complement their own “true” identity. In the present study, potentially relevant factors influencing the quality of life of BID sufferers in the context of their coming-out process were examined. A questionnaire survey was used to ask BID sufferers (N = 50) about the reactions of their …

Effect of chronic administration of Aloe vera extract on plasma biochemistry in rabbits

Amjad Ali Channa,

Saeed Ahmed Soomro,

Roshan Ali Korejo,

Band-e-Ali Khaskeli,

Tofique Ahmed Qureshi,

Imtiaz Ahmed Shah,

Nawab Ali Kalhoro,

Hinesh Kumar Maheshwari

Опубликована Авг. 30, 2014

Due to excessive use, synthetic medicines are going to be expensive and resistant, their residues accumulate in blood, that is why slowly and gradually they become resistant. Alternatives to synthetic medicines are herbal medicines that are cheap, with minimum or no side effect. Previous studies found that liquid extract of Aloe vera plant proved beneficial for animal’s health as it has immune-modulating, hypolipidemic, hypoglycemic and haematinic effects. The aim of this study was to investigate the effect of A. vera extract on plasma biochemistry. A total of twenty (n = 20) male rabbits were selected and divided into 4 groups; …

Medical treatment of the complication of first trimester pregnancy loss with misoprostol

Naushaba Rizwan,

Syed Farhan Uddin

Опубликована Сен. 30, 2014

The objective of the study was to evaluate the efficacy of misoprostol in patients with complication of first trimester pregnancy loss. After the departmental approval, a total of 102 women with first trimester pregnancy failure were recruited for treatment with misoprostol. The inclusion criteria were gestational age of less than 12 weeks and hemodynamically stable. The exclusion criteria were patients with history of hypersensitivity to prostaglandin, bronchial asthma and hemoglobin less than 9 g. Main outcome measures were the successful resolution of miscarriages without surgical intervention; secondary outcomes were incidence of pain, vaginal bleeding, infection, pyrexia and gastrointestinal side effects. …